XML 14 R12.htm IDEA: XBRL DOCUMENT

Accrued Expense	9 Months Ended
Accrued Expense	Sep. 30, 2011
Accrued Expense	5. Accrued Expense As of September 30, 2011, Current Liabilities included accrued expense of $111,862. R&D expenses related to MD Anderson treating patients in the Phase I clinical trial comprised $100,000 of this amount. Accrued expenses for corporate communication and travel to suppliers, meetings and conferences represented the balance of accrued expenses.